WallStSmart

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)vsPetMed Express Inc (PETS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PetMed Express Inc generates 820% more annual revenue ($186.96M vs $20.31M). HKPD leads profitability with a -0.1% profit margin vs -34.7%. PETS earns a higher WallStSmart Score of 43/100 (D).

HKPD

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 2.5Value: 5.0Quality: 5.0

PETS

Hold

43

out of 100

Grade: D

Growth: 2.7Profit: 2.0Value: 6.7Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HKPD2 strengths · Avg: 10.0/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

EPS GrowthGrowth
130.2%10/10

Earnings expanding 130.2% YoY

PETS1 strengths · Avg: 8.0/10
Price/BookValuation
1.5x8/10

Reasonable price relative to book value

Areas to Watch

HKPD4 concerns · Avg: 2.3/10
Market CapQuality
$6.99M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-0.6%2/10

ROE of -0.6% — below average capital efficiency

Revenue GrowthGrowth
-4.7%2/10

Revenue declined 4.7%

Free Cash FlowQuality
$-106,3932/10

Negative free cash flow — burning cash

PETS4 concerns · Avg: 3.3/10
PEG RatioValuation
2.324/10

Expensive relative to growth rate

EPS GrowthGrowth
2.7%4/10

2.7% earnings growth

Market CapQuality
$49.22M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-100.6%2/10

ROE of -100.6% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : HKPD

The strongest argument for HKPD centers on Price/Book, EPS Growth.

Bull Case : PETS

The strongest argument for PETS centers on Price/Book.

Bear Case : HKPD

The primary concerns for HKPD are Market Cap, Return on Equity, Revenue Growth.

Bear Case : PETS

The primary concerns for PETS are PEG Ratio, EPS Growth, Market Cap.

Key Dynamics to Monitor

HKPD is growing revenue faster at -4.7% — sustainability is the question.

HKPD generates stronger free cash flow (-106,393), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PETS scores higher overall (43/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Hong Kong Pharma Digital Technology Holdings Limited is a pioneering company at the intersection of biotechnology and digital healthcare, focusing on the integration of cutting-edge technology with pharmaceutical services to enhance patient outcomes and streamline healthcare delivery. Leveraging advanced digital solutions and data analytics, the company optimizes drug development processes and improves operational efficiencies, positioning itself as a critical player in the evolving healthcare landscape. With a strong commitment to health technology advancement and the cultivation of strategic alliances, Hong Kong Pharma is poised to meet the demands of both domestic and global markets while driving innovation across its pharmaceutical service offerings.

PetMed Express Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

PetMed Express, Inc., doing business as 1-800-PetMeds, is a pet pharmacy in the United States. The company is headquartered in Delray Beach, Florida.

Want to dig deeper into these stocks?